SMITH STAN purchased 1.9% of their position (25K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $24.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/26/2025ACC: 0001878313-25-000045
+25K
Net shares
Net buyer
$24.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
25K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+10K
Price / share
$0.99
Trade value
$9.90K
% of position
0.8%
11/24/2025
1.32M→1.33M
Common Stock
Indirect
Shares
+15K
Price / share
$0.98
Trade value
$14.70K
% of position
1.1%
11/25/2025
1.33M→1.35M
Total
Net shares
+25K
Net value
$24.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/24/2025 | P · Purchase | +10K | $0.99 | $9.90K | 0.8% | 1.32M | 1.33M |
| Common Stock Indirect | 11/25/2025 | P · Purchase | +15K | $0.98 | $14.70K | 1.1% | 1.33M | 1.35M |
| Total | +25K | $24.60K | ||||||
Derivative Transactions0
No derivative transactions reported